Home › Drug Codes › J Codes › J2260 · MILRINONE IN 5% DEXTROSE
Updated July 1st, 2026

MILRINONE IN 5% DEXTROSE J Code: J2260

Injection, milrinone lactate, 5 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J2260, effective October 1, 2026: $1.143 per HCPCS billing unit, up 4.1% from $1.098. From CMS's final file.

?
Medicare Payment Limit ?
$1.098
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
35
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, milrinone lactate, 5 mg
HCPCS Added Date January 1, 1986
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection, Solution

About MILRINONE IN 5% DEXTROSE

Milrinone IN 5% Dextrose is a medication aligned to the HCPCS J Code: J2260 for billing, pricing, and reimbursement purposes in the United States. It is a Cardiology drug administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: This medication is used for the short-term treatment of heart failure. It works by making your heart beat stronger and by relaxing certain blood vessels so that the amount of blood that is pumped from the heart is increased. This effect may help with symptoms of heart failure (such as shortness of breath, tiredness).

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 35 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00143-9326-10 Milrinone Lactate Hikma Pharmaceuticals USA Inc. 40 20 MG / 20 ML
00338-6010-48 Milrinone Lactate in Dextrose Baxter Healthcare Corporation 4 20 MG / 100 ML
00409-0212-01 Milrinone Lactate Hospira, Inc. 20 10 MG / 10 ML
25021-0313-82 Milrinone Lactate in Dextrose Sagent Pharmaceuticals 40 20 MG / 100 ML
55150-0287-10 Milrinone Lactate Eugia US LLC 40 20 MG / 100 ML
•••••-••••-•• Log in to view MILRINONE IN 5% DEXTROSE
MILRINONE IN 5% DEXTROSE
MILRINONE IN 5% DEXTROSE
Login to view 30 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

MILRINONE IN 5% DEXTROSE Pricing & Reimbursement

J2260 Private Payer Reimbursement
$1.30 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

MILRINONE IN 5% DEXTROSE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Milrinone IN 5% Dextrose (J2260) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J2260. Wastage billing guide →

MILRINONE IN 5% DEXTROSE Medically Unlikely Edits (MUE)

The most billing units of J2260 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 5 mg. The limit is different in the office and the hospital. Use the one for your setting.

Practitioner Office
4 units / day
= 20 mg per day
Hospital Outpatient
16 units / day
= 80 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

MILRINONE IN 5% DEXTROSE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute Decompensated Heart Failure Acute decompensated heart failure
Drug Class
Phosphodiesterase 3 Inhibitor [EPC]Phosphodiesterase 3 Inhibitors [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Milrinone In 5% Dextrose billing and coding guide?
We have not yet identified a manufacturer source of Milrinone In 5% Dextrose billing and coding information.
Are there any available Milrinone In 5% Dextrose patient assistance programs?
Our team did not identify a source for Milrinone In 5% Dextrose patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Milrinone In 5% Dextrose prescribing information?
Our team is still working to identify a prescribing information source for MILRINONE IN 5% DEXTROSE
Where can I find Milrinone In 5% Dextrose side effect information?
Our team has not yet identified a source of side effects information for MILRINONE IN 5% DEXTROSE. Please check back in a few weeks.
Does billing MILRINONE IN 5% DEXTROSE require JZ/JW wastage modifiers?
CMS does not include MILRINONE IN 5% DEXTROSE (J2260) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J2260. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to MILRINONE IN 5% DEXTROSE.

C9248CLEVIPREXInjection, clevidipine butyrate, 1 mgChiesi USAAdded January 1, 2009C9482SOTALOL HCLInjection, sotalol hydrochloride, 1 mgAltathera PharmaceuticalsAdded October 1, 2016J0130ABCIXIMABInjection abciximab, 10 mgAdded January 1, 1999J0153ADENOCARDInjection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)Multiple ManufacturersAdded January 1, 2015J0162EPINEPHRINE HCLInjection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mgFresenius KabiAdded January 1, 2026J0163ADRENALINInjection, epinephrine in sodium chloride (endo), 0.1 mgPar Pharmaceutical, IncAdded October 1, 2025J0164EPINEPHRINE (BAXTER)Injection, epinephrine in sodium chloride (baxter), 0.1 mgBaxter HealthcareAdded October 1, 2025J0165EPINEPHRINE HCLInjection, epinephrine, not otherwise specified, 0.1 mgMultiple ManufacturersAdded July 1, 2025J0166EPINEPHRINE HCL (BELCHER)Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mgMultiple ManufacturersAdded July 1, 2025J0167EPINEPHRINE HCLInjection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mgMultiple ManufacturersAdded July 1, 2025